Diagnosis and blood therapy of Rh(D/E)hemolytic diseases caused by maternal-fetal blood group incompatibility
Chinese journal of immunology(2007)
摘要
Objective:To investigate the therapy of Rh(D/E)hemolytic diseases caused by maternal-fetal blood group incompatibility,prevent the spontaneous abortion and fatal death.Methods:A substitution transfusion special by multiplicity removal and manipulus replenishment was used for the therapy of Rh(D/E)hemolytic diseases caused by maternal-fetal blood group incompatibility,it could cut down the quantity of special anti-D/E IgG,improve the survival rate of fetus and newborns.Results:Two mothers with Rh(D)hemolytic diseases had high titer anti-D IgG(1∶512 and 1∶1 024)before substitution transfusion,but it decreased to(1∶16 and 1∶32)3 weeks after substitution transfusion,and their low anti-D IgG(≤64)were maintained after treated with interval substitution transfusion,by the end they give birth to a male and a female baby with uterine-incision delivery.A Rh(E)hemolytic diseases mother who did treated with substitution transfusion ended her pregnancy by dead fetus in uterus,another Rh(D)hemolytic diseases mother without substitution transfusion deliver a baby with Rh(D)hemolytic diseases,who was survived after substitution transfusion.Three children were health after 1 year's follow-up visiting.Conclusion:Substitution transfusion with multiplicity removal and manipulus replenishment,company with high protein food is a efficient therapy for Rh(D/E)hemolytic diseases mother,and it is a best choice for newborns with Rh(D/E)hemolytic diseases.
更多查看译文
关键词
blood therapy,diagnosis,diseases,maternal-fetal
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要